Novavax signs agreement with European Commission for COVID19 vaccine
Deal for 100 million doses with additional 100 million through 2023
Deal for 100 million doses with additional 100 million through 2023
PegIFN in COVID19 has several add-on advantages compared to other anti-viral agents
Subscribe To Our Newsletter & Stay Updated